ADC Therapeutics SA (ADCT) Appoints Jean-Pierre Bizzari to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PTC
3. PCVX
4. SPY
5. META
6. MSFT
7. USO
8. AMD
9. GMAB
10. BBIO

Go back to ADC Therapeutics SA (ADCT) Appoints Jean-Pierre Bizzari to its Board

ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors

July 1, 2022 7:15 AM EDT

Ameet Mallik, Chief Executive Officer of ADC Therapeutics, also joins the Board

LAUSANNE, Switzerland--(BUSINESS WIRE)-- ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of veteran oncology drug developer Jean-Pierre Bizzari, MD, to its Board of Directors. Additionally, Ameet Mallik, who was appointed as the Companys Chief Executive Officer in May 2022, will join the Board.

This press release features multimedia. View the full release here:... More